Last $60.55 USD
Change Today +0.67 / 1.12%
Volume 547.2K
DXCM On Other Exchanges
Symbol
Exchange
DXCM is not on other exchanges.
As of 5:20 PM 03/5/15 All times are local (Market data is delayed by at least 15 minutes).

dexcom inc (DXCM) Key Developments

DexCom, Inc. Provides Product Revenue Guidance for the Year 2015

DexCom, Inc. provided product revenue guidance for the year 2015 of between $340 million and $360 million.

DexCom, Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014

DexCom, Inc. reported consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported total revenue of $84.3 million compared to $51.7 million a year ago. Operating income was $1.6 million compared to operating loss of $2.3 million a year ago. Income before income taxes was $1.4 million compared to loss before income taxes of $2.6 million a year ago. Net income was $1.3 million or $0.02 per diluted share compared to net loss of $2.6 million or $0.04 per basic and diluted share a year ago. For the year, the company reported total revenue of $259.2 million compared to $160 million a year ago. Operating loss was $21.5 million compared to $28.9 million a year ago. Loss before income taxes was $22.3 million compared to $29.8 million a year ago. Net loss was $22.4 million or $0.30 per basic and diluted share compared to $29.8 million or $0.42 per basic and diluted share a year ago.

DexCom, Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 09:15 AM

DexCom, Inc. Presents at Raymond James & Associates 36th Annual Institutional Investors Conference, Mar-03-2015 09:15 AM. Venue: JW Marriott Grande Lakes, 4040 Central Florida Parkway, Orlando, FL 32837, United States. Speakers: Steven R. Pacelli, Executive Vice President of Strategy & Corporate Development.

DexCom, Inc. to Report Q4, 2014 Results on Feb 25, 2015

DexCom, Inc. announced that they will report Q4, 2014 results at 4:30 PM, US Eastern Standard Time on Feb 25, 2015

DexCom, Inc., Q4 2014 Earnings Call, Feb 25, 2015

DexCom, Inc., Q4 2014 Earnings Call, Feb 25, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DXCM:US $60.55 USD +0.67

DXCM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Insulet Corp $31.98 USD +1.02
Merge Healthcare Inc $4.61 USD 0.00
NeuStar Inc $22.83 USD +0.58
Radview Software Ltd $0.0016 USD 0.00
Tandem Diabetes Care Inc $13.43 USD +0.78
View Industry Companies
 

Industry Analysis

DXCM

Industry Average

Valuation DXCM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 17.7x
Price/Book 33.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 17.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEXCOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.